HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Carlos Gomez-Roca Selected Research

Aspartate Aminotransferases (Aspartate Transaminase)

12/2020Phase I Trial of Debio 1143, an Antagonist of Inhibitor of Apoptosis Proteins, Combined with Cisplatin Chemoradiotherapy in Patients with Locally Advanced Squamous Cell Carcinoma of the Head and Neck.
10/2020Phase Ib study of anti-CSF-1R antibody emactuzumab in combination with CD40 agonist selicrelumab in advanced solid tumor patients.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Carlos Gomez-Roca Research Topics

Disease

39Neoplasms (Cancer)
04/2024 - 08/2009
5Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2021 - 09/2009
4Fatigue
04/2024 - 04/2016
4Colorectal Neoplasms (Colorectal Cancer)
01/2023 - 02/2014
3Neoplasm Metastasis (Metastasis)
01/2023 - 08/2009
3Mesothelioma
01/2023 - 09/2009
3Melanoma (Melanoma, Malignant)
01/2021 - 09/2017
2Asthenia
04/2024 - 12/2018
2Pneumonia (Pneumonitis)
04/2024 - 09/2009
2Carcinoma (Carcinomatosis)
11/2023 - 01/2016
2Malignant Mesothelioma
01/2023 - 09/2009
2Squamous Cell Carcinoma (Epidermoid Carcinoma)
01/2022 - 12/2020
2Exanthema (Rash)
01/2022 - 12/2018
2Edema (Dropsy)
01/2021 - 10/2020
2Giant Cell Tumors (Giant Cell Tumor)
01/2021 - 06/2014
2Febrile Neutropenia
12/2020 - 12/2018
2Glioblastoma (Glioblastoma Multiforme)
02/2019 - 10/2016
2Diarrhea
12/2018 - 12/2018
2Renal Cell Carcinoma (Grawitz Tumor)
11/2017 - 01/2017
1Chemical and Drug Induced Liver Injury
04/2024
1Pancreatic Neoplasms (Pancreatic Cancer)
01/2024
1Biliary Tract Neoplasms (Biliary Tract Cancer)
01/2022
1Adenocarcinoma
01/2021
1Body Weight (Weight, Body)
01/2021
1Necrosis
12/2020
1Anemia
12/2020
1Squamous Cell Carcinoma of Head and Neck
12/2020
1Capillary Leak Syndrome
11/2020
1Lung Neoplasms (Lung Cancer)
11/2020
1Hypotension (Low Blood Pressure)
11/2020
1Sjogren's Syndrome (Sjogren Syndrome)
01/2020
1Head and Neck Neoplasms (Head and Neck Cancer)
01/2020
1Ovarian Neoplasms (Ovarian Cancer)
01/2019

Drug/Important Bio-Agent (IBA)

7Immune Checkpoint InhibitorsIBA
01/2023 - 10/2017
5Biomarkers (Surrogate Marker)IBA
07/2022 - 08/2009
4pembrolizumabIBA
01/2023 - 01/2017
4emactuzumabIBA
01/2022 - 06/2014
4Monoclonal AntibodiesIBA
01/2022 - 10/2011
3LigandsIBA
11/2023 - 12/2017
3Cisplatin (Platino)FDA LinkGeneric
01/2022 - 09/2009
3CreatinineIBA
12/2020 - 10/2020
3EverolimusFDA Link
11/2017 - 10/2011
3Antineoplastic Agents (Antineoplastics)IBA
01/2016 - 01/2014
2Immunoglobulins (Immunoglobulin)IBA
04/2024 - 11/2016
2Proteins (Proteins, Gene)FDA Link
04/2024 - 08/2009
2Tyrosine Kinase InhibitorsIBA
01/2024 - 01/2023
2atezolizumabIBA
11/2023 - 01/2022
2PlatinumIBA
11/2023 - 01/2019
2Sorafenib (BAY 43-9006)FDA Link
06/2023 - 01/2018
2IntegrinsIBA
01/2023 - 01/2018
2CytokinesIBA
01/2023 - 01/2021
2Neoplasm Antigens (Tumor Antigens)IBA
07/2022 - 01/2021
2regorafenibIBA
01/2022 - 01/2021
2avelumabIBA
01/2022 - 01/2021
2Macrophage Colony-Stimulating FactorIBA
01/2021 - 10/2020
2Indicators and Reagents (Reagents)IBA
01/2021 - 01/2014
2N- (2,3- dihydroxypropyl)- 1- ((2- fluoro- 4- iodophenyl)amino)isonicotinamideIBA
01/2021 - 01/2021
2Aspartate Aminotransferases (Aspartate Transaminase)IBA
12/2020 - 10/2020
2Alanine Transaminase (SGPT)IBA
12/2020 - 01/2018
2AfatinibIBA
12/2018 - 12/2018
2RG7356IBA
11/2016 - 05/2016
2OTX015IBA
04/2016 - 01/2016
2imgatuzumabIBA
02/2014 - 10/2011
2ErbB Receptors (EGF Receptor)IBA
10/2011 - 10/2009
1Transaminases (Aminotransferases)IBA
04/2024
1Interleukin-2 (IL2)IBA
04/2024
1durvalumabIBA
01/2024
1Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA
01/2024
1pexidartinibIBA
01/2024
1tocilizumab (atlizumab)FDA Link
11/2023
1niraparibIBA
11/2023
1magrolimabIBA
11/2023
1Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
01/2023
1nintedanibIBA
01/2023
1Interleukin-6 (Interleukin 6)IBA
01/2023
1Exonucleases (3' 5' Exonuclease)IBA
01/2022
1DNA (Deoxyribonucleic Acid)IBA
01/2022
1NivolumabIBA
01/2022
1Peptide Hydrolases (Proteases)FDA Link
01/2021
1CrizotinibIBA
01/2021
1Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA
01/2021
1Mitogen-Activated Protein Kinase Kinases (MEKs)IBA
01/2021
1Matrix Metalloproteinases (MMPs)IBA
01/2021
1GTP Phosphohydrolases (GTPases)IBA
01/2021
1Proteoglycans (Proteoglycan)IBA
01/2021
1Protein Serine-Threonine Kinases (Protein-Serine-Threonine Kinase)IBA
01/2021
1Inhibitor of Apoptosis ProteinsIBA
12/2020
1Lipase (Acid Lipase)FDA Link
12/2020
1MesothelinIBA
11/2020
1LMB-100IBA
11/2020
1Surface Antigens (Surface Antigen)IBA
11/2020
1Immunotoxins (Immunotoxin)IBA
11/2020
1EnzymesIBA
11/2020
1selicrelumabIBA
10/2020
1PolyaminesIBA
01/2019

Therapy/Procedure

9Therapeutics
01/2023 - 09/2009
8Immunotherapy
11/2023 - 05/2014
4Chemoradiotherapy
01/2022 - 01/2018
3Radiotherapy
01/2021 - 10/2016
1Injections
01/2019